Skip to main content
Jochen Reiser, MD, Nephrology, Chicago, IL

JochenReiserMDPh.D.

Nephrology Chicago, IL

Professor and Chairman of Medicine at Rush University Medical Center

Dr. Reiser is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Reiser's full profile

Already have an account?

  • Office

    1611 W. Harrison Street
    Suite 510
    Chicago, IL 60612
    Phone+1 312-942-6639
    Fax+1 312-942-5271

Education & Training

  • Brigham and Women's Hospital/Massachusetts General Hospital
    Brigham and Women's Hospital/Massachusetts General HospitalFellowship, Nephrology, 2003 - 2005
  • Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)
    Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 2000 - 2003
  • University of Heidelberg Faculty of Medicine
    University of Heidelberg Faculty of MedicineClass of 1998

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 2013 - 2026
  • TX State Medical License
    TX State Medical License 2023 - 2024
  • FL State Medical License
    FL State Medical License 2008 - 2013
  • MA State Medical License
    MA State Medical License 2005 - 2010

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 2009

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Association Between Early Treatment with Tocilizumab and Mortality Among Critically Ill Patients with COVID-19  
    Kusum S Mathews, Michal L Melamed, Samantha K Brenner, Amanda Leonberg-Yoo, Edward J Schenck, Jared Radbel, Jochen Reiser, Anip Bansal, Diana Finkel, Mary Mallappallil..., JAMA Internal Medicine
  • Factors Associated with Death in Critically Ill Patients with Coronavirus Disease 2019 in the US  
    Kusum S Mathews, Michal L Melamed, Samantha K Brenner, Amanda Leonberg-Yoo, Edward J Schenck, Jared Radbel, Jochen Reiser, Anip Bansal, Alexandre M Shehata, Nitender G..., JAMA Internal Medicine
  • Soluble Urokinase Plasminogen Activator Receptor (suPAR) Is Predictive of Non-AIDS Events During Antiretroviral Therapy-Mediated Viral Suppression  
    Michael M Lederman, Jochen Reiser, Clinical Infectious Diseases

Authored Content

  • Factors Associated with Death in Critically Ill Patients with Coronavirus Disease 2019 in the USJuly 2020
  • Factors Associated with Death in Critically Ill Patients with Coronavirus Disease 2019 in the USJuly 2020
  • Factors Associated with Death in Critically Ill Patients with Coronavirus Disease 2019 in the USJuly 2020
  • Soluble Urokinase Receptor and Acute Kidney InjuryJanuary 2020
  • Join now to see all

Press Mentions

  • 87 Industry Leaders Reveal Their Secrets to Elevating Patient Care
    87 Industry Leaders Reveal Their Secrets to Elevating Patient CareAugust 29th, 2024
  • Scientists Discover New Immune Target to Treat Cardiovascular Disease
    Scientists Discover New Immune Target to Treat Cardiovascular DiseaseDecember 16th, 2022
  • Study Uncovers New Immune Target to Treat Atherosclerosis
    Study Uncovers New Immune Target to Treat AtherosclerosisDecember 16th, 2022
  • Join now to see all